Deep Learning for Personalized Pharmacotherapy in Pregnant Women with Psychiatric Disorders

Managing psychiatric disorders, including depression, anxiety, and bipolar disorder, during pregnancy presents significant clinical challenges due to uncertainties surrounding medication safety and efficacy for both the mother and fetus.This study introduces a novel deep learning (DL)-based decision-support framework aimed at personalizing pharmacotherapy for pregnant patients diagnosed with psychiatric conditions.By leveraging electronic health records (EHRs), pharmacogenomic data, and advanced machine learning techniques, we developed a predictive neural network model capable of recommending precise drug classes and dosages tailored to individual patient profiles.Our methodology consisted of clearly defined sequential phases: problem definition, data collection, preprocessing, feature engineering, exploratory data analysis (EDA), model development, genetic data integration, validation, and deployment into clinical practice.Exploratory analysis revealed critical insights, identifying significant predictors of medication efficacy and side effects through visualizations including pair plots, correlation heatmaps, violin plots, and interactive scatter plots.The developed neural network model, optimized using rigorous hyperparameter tuning, exhibited high accuracy and robust predictive power, as evidenced by outstanding ROC-AUC and precisionrecall performance metrics.Integration of pharmacogenomic data further improved predictive accuracy, demonstrating the model's ability to capture complex genetic interactions influencing drug response variability.Rigorous validation through retrospective cohort studies confirmed the clinical applicability and reliability of our system.Ultimately, our decision-support tool provides clinicians with evidence-based, individualized medication strategies that effectively balance therapeutic outcomes and safety concerns during pregnancy.The application of this DL-driven personalized pharmacotherapy framework How to cite this paper:

Authors

Publication Details

Journal
OALib
Published
2025-01-01
DOI
https://doi.org/10.4236/oalib.1113512
Primary Topic
Maternal Mental Health During Pregnancy and Postpartum
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Deep Learning for Personalized Pharmacotherapy in Pregnant Women with Psychiatric Disorders

Rocco de Filippis, Abdullah Al Foysal
OALib
Maternal Mental Health During Pregnancy and Postpartum
article

Deep Learning for Personalized Pharmacotherapy in Pregnant Women with Psychiatric Disorders

Rocco de Filippis, Abdullah Al Foysal
article en

Abstract

Managing psychiatric disorders, including depression, anxiety, and bipolar disorder, during pregnancy presents significant clinical challenges due to uncertainties surrounding medication safety and efficacy for both the mother and fetus.This study introduces a novel deep learning (DL)-based decision-support framework aimed at personalizing pharmacotherapy for pregnant patients diagnosed with psychiatric conditions.By leveraging electronic health records (EHRs), pharmacogenomic data, and advanced machine learning techniques, we developed a predictive neural network model capable of recommending precise drug classes and dosages tailored to individual patient profiles.Our methodology consisted of clearly defined sequential phases: problem definition, data collection, preprocessing, feature engineering, exploratory data analysis (EDA), model development, genetic data integration, validation, and deployment into clinical practice.Exploratory analysis revealed critical insights, identifying significant predictors of medication efficacy and side effects through visualizations including pair plots, correlation heatmaps, violin plots, and interactive scatter plots.The developed neural network model, optimized using rigorous hyperparameter tuning, exhibited high accuracy and robust predictive power, as evidenced by outstanding ROC-AUC and precisionrecall performance metrics.Integration of pharmacogenomic data further improved predictive accuracy, demonstrating the model's ability to capture complex genetic interactions influencing drug response variability.Rigorous validation through retrospective cohort studies confirmed the clinical applicability and reliability of our system.Ultimately, our decision-support tool provides clinicians with evidence-based, individualized medication strategies that effectively balance therapeutic outcomes and safety concerns during pregnancy.The application of this DL-driven personalized pharmacotherapy framework How to cite this paper:

OALibVol. 12(06)
Gender equality
Openalex Percentile: Top 82%
Maternal Mental Health During Pregnancy and Postpartum
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Deep Learning for Personalized Pharmacotherapy in Pregnant Women with Psychiatric Disorders — Rocco de Filippis, Abdullah Al Foysal · OALib (2025) | TGRS Research Map | TGRS